- Report
- April 2024
- 180 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2022
- 213 Pages
Global
From €4739EUR$5,050USD£3,950GBP
- Report
- August 2018
- 211 Pages
Global
From €1335EUR$1,375USD£1,152GBP
€2671EUR$2,750USD£2,304GBP
- Report
- April 2024
- 185 Pages
From €4759EUR$4,900USD£4,106GBP
- Report
- April 2019
- 188 Pages
Europe
From €2040EUR$2,100USD£1,760GBP
€2914EUR$3,000USD£2,514GBP
- Report
- June 2022
- 297 Pages
Global
From €5603EUR$5,769USD£4,834GBP
The Dna Editing market is a subset of the larger Genomics industry, which focuses on the study of genetic material. It involves the manipulation of genetic material to alter the characteristics of an organism. This includes techniques such as gene editing, gene therapy, and gene silencing. Dna Editing is used to modify the genetic code of an organism, allowing for the introduction of new traits or the removal of existing ones. It is used in a variety of applications, including agriculture, medicine, and research.
The Dna Editing market is growing rapidly, driven by advances in technology and the increasing demand for precision medicine. Companies in the market are developing new tools and techniques to make the process more efficient and cost-effective.
Some companies in the Dna Editing market include Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, and Beam Therapeutics. Show Less Read more